Christoph Brackmann
Keine laufenden Positionen mehr
Profil
Christoph Brackmann worked as the Global Head of Investor Relations and Head of Finance International at Shire Plc from 2017 to 2018.
Ehemalige bekannte Positionen von Christoph Brackmann
| Unternehmen | Position | Ende |
|---|---|---|
| SHIRE | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
